Clinical Trial Update: Pemetrexed Disodium and Carboplatin or Cisplatin With or Without Erlotinib Hydrochloride in Treating Patient With Stage IV Non-Small Cell Lung Cancer Resistant to First-Line Therapy With Erlotinib Hydrochloride or Gefitinib [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating pemetrexed disodium with carboplatin or cisplatin, with or without erlotinib, for stage IV non-small cell lung cancer resistant to fi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• Erlotinib hydrochloride (Erlotinib)
• Pemetrexed disodium (Pemetrexed disodium)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Recurrent Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer | Phase 2 | Status: WITHDRAWN